Trials / Completed
CompletedNCT03862469
Premenstrual Hormonal and Affective State Evaluation (PHASE) Project
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 129 (actual)
- Sponsor
- University of Illinois at Chicago · Academic / Other
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
PHASE is designed to evaluate neuroactive hormone trajectories across the menstrual cycle and endocrine, autonomic, and subjective responses to psychosocial stress in women suffering from severe PMS (i.e., premenstrual dysphoric disorder).
Detailed description
Female volunteers will be recruited from the community for participation in this 3-menstrual cycle study. In the first two menstrual cycles, study participants will chart their symptoms and and ovulation. Study participants will continue to perform ovulation testing during their third menstrual cycle in which they will attend one individualized task session and provide 8 serum samples at different timepoints across the menstrual cycle. Primary analyses will contrast neuroactive hormone trajectories across the menstrual cycle and stress reactivity according to study groups (PMDD vs healthy).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Individualized laboratory test | Laboratory test administered between 6 and 2 days prior to the subsequent menstrual cycle. |
Timeline
- Start date
- 2019-09-26
- Primary completion
- 2023-09-01
- Completion
- 2023-09-01
- First posted
- 2019-03-05
- Last updated
- 2025-04-24
- Results posted
- 2025-04-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03862469. Inclusion in this directory is not an endorsement.